Chatillon O, Even C. Antepartum depression: prevalence, diagnosis and treatment. Encephale. 2010;36:443–51.
Google Scholar
Gelaye B, Rondon MB, Araya R, Williams MA. Epidemiology of maternal depression, risk factors, and child outcomes in low-income and middle-income countries. Lancet Psychiatry. 2016;3:973–82.
Google Scholar
Hallberg P, Sjöblom V. The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects. J Clin Psychopharmacol. 2005;25:59–73.
Google Scholar
Abdullah H, Beckmann J, Andonian-Dierks C. Empirical findings on associations between anxiety, depression, and congenital heart disease in adults – a systematic review and meta-analysis. Heart Mind. 2023;7:70–9.
Google Scholar
Munir LZ, du Toit EF. Impact of chronic psychological stress on cardiovascular disease risk: a narrative review. Heart Mind. 2024;8:268–78.
Google Scholar
Meunier MR, Bennett IM, Coco AS. Use of antidepressant medication in the United States during pregnancy, 2002–2010. Psychiatr Serv. 2013;64:1157–60.
Google Scholar
Damkier P, Christensen LS, Broe A. Patterns and predictors for prescription of psychotropics and mood-stabilizing antiepileptics during pregnancy in Denmark 2000–2016. Br J Clin Pharmacol. 2018;84:2651–62.
Google Scholar
Latendresse G, Elmore C, Deneris A. Selective serotonin reuptake inhibitors as first-line antidepressant therapy for perinatal depression. J Midwifery Womens Health. 2017;62:317–28.
Google Scholar
Bałkowiec-Iskra E, Mirowska-Guzel DM, Wielgoś M. Effect of antidepressants use in pregnancy on foetus development and adverse effects in newborns. Ginekol Pol. 2017;88:36–42.
Google Scholar
Mesches GA, Wisner KL, Betcher HK. A common clinical conundrum: antidepressant treatment of depression in pregnant women. Semin Perinatol. 2020;44:151229.
Google Scholar
Vlenterie R, van Gelder M, Anderson HR, Andersson L, Broekman BFP, Dubnov-Raz G, et al. Associations between maternal depression, antidepressant use during pregnancy, and adverse pregnancy outcomes: an individual participant data meta-analysis. Obstet Gynecol. 2021;138:633–46.
Google Scholar
Ghimire U, Papabathini SS, Kawuki J, Obore N, Musa TH. Depression during pregnancy and the risk of low birth weight, preterm birth and intrauterine growth restriction- an updated meta-analysis. Early Hum Dev. 2021;152:105243.
Google Scholar
Guan HB, Wei Y, Wang LL, Qiao C, Liu CX. Prenatal selective serotonin reuptake inhibitor use and associated risk for gestational hypertension and preeclampsia: a Meta-analysis of Cohort studies. J Womens Health (Larchmt). 2018;27:791–800.
Google Scholar
Arafa A, Dong JY. Depression and risk of gestational diabetes: a meta-analysis of cohort studies. Diabetes Res Clin Pract. 2019;156:107826.
Google Scholar
Leshem R, Bar-Oz B, Diav-Citrin O, Gbaly S, Soliman J, Renoux C, et al. Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine ReuptakeInhibitors (SNRIs) During Pregnancy and the Risk for Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) in the offspring: a true effect or a bias? A systematic review & meta-analysis. Curr Neuropharmacol. 2021;19:896–906.
Google Scholar
Jarde A, Morais M, Kingston D, Giallo R, MacQueen GM, Giglia L, et al. Neonatal outcomes in women with untreated antenatal depression compared with women without depression: a systematic review and meta-analysis. JAMA Psychiatry. 2016;73:826–37.
Google Scholar
Uguz F. Neonatal and childhood outcomes in offspring of oregnant women using antidepressant medications: a critical review of current meta-analyses. J Clin Pharmacol. 2021;61:146–58.
Google Scholar
Dragioti E, Solmi M, Favaro A, Fusar-Poli P, Dazzan P, Thompson T, et al. Association of antidepressant use with adverse health outcomes: a systematic umbrella review. JAMA Psychiatry. 2019;76:1241–55.
Google Scholar
Ankarfeldt MZ, Petersen J, Andersen JT, Fernandes MFS, Li H, Motsko SP, et al. Duloxetine exposure during pregnancy and the risk of spontaneous and elective abortion: a Danish Nationwide Observational study. Drugs Real World Outcomes. 2021;8:289–99.
Google Scholar
Berard A, Zhao JP, Sheehy O. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. BMJ Open. 2017;7:e013372.
Google Scholar
Reis M, Kallen B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med. 2010;40:1723–33.
Google Scholar
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.
Google Scholar
Adeoye IA, Unogu CO, Adediran K, Gbadebo BM. Determinants of adverse perinatal outcomes in Ibadan, Nigeria: the influence of maternal lifestyle. PLOS Glob Public Health. 2025;5:e0004199.
Google Scholar
Al Rawahi A, Al Kiyumi MH, Al Kimyani R, Al-Lawati I, Murthi S, Davidson R, et al. The effect of antepartum depression on the outcomes of pregnancy and development of postpartum depression: a Prospective Cohort study of Omani women. Sultan Qaboos Univ Med J. 2020;20:e179–86.
Google Scholar
Avalos LA, Chandran A, Churchill ML, Gao X, Ames JL, Nozadi SS, et al. Prenatal depression and risk of child autism-related traits among participants in the Environmental influences on Child Health Outcomes program. Autism Res. 2023;16:1825–35.
Google Scholar
Beyene GM, Azale T, Gelaye KA, Ayele TA. The effect of antenatal depression on birth weight among newborns in South Gondar zone, Northwest Ethiopia: a Population-Based Prospective Cohort study. Arch Public Health. 2021;79:121.
Google Scholar
Bindt C, Guo N, Bonle MT, Appiah-Poku J, Hinz R, Barthel D, et al. No association between antenatal common mental disorders in low-obstetric risk women and adverse birth outcomes in their offspring: results from the CDS study in Ghana and Cote D’Ivoire. PloS one. 2013;8:e80711.
Google Scholar
Bitew T, Hanlon C, Kebede E, Honikman S, Fekadu A. Antenatal depressive symptoms and perinatal complications: a Prospective study in rural Ethiopia. BMC psychiatry. 2017;17:301.
Google Scholar
Björvang RD, Liakea I, Carpentsier B, Kozinszky Z, Skalkidou A, Fransson E. Association of diabetes mellitus in pregnancy and perinatal depression. Psychosom Med. 2024;86:52–8.
Google Scholar
Chang HY, Keyes KM, Lee KS, Choi IA, Kim SJ, Kim KW, et al. Prenatal maternal depression is associated with low birth weight through shorter gestational age in term infants in Korea. Early Hum Dev. 2014;90:15–20.
Google Scholar
Chen XN, Hu Y, Hu WH, Xia X, Li XT. Risk of adverse perinatal outcomes and antenatal depression based on the zung self-rating depression scale. Rep Dev Med. 2021;5:23–9.
Google Scholar
Chung TK, Lau TK, Yip AS, Chiu HF, Lee DT. Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosom Med. 2001;63:830–4.
Google Scholar
Dadi AF, Miller ER, Woodman RJ, Azale T, Mwanri L. Effect of antenatal depression on adverse birth outcomes in Gondar town, Ethiopia: a Community-Based Cohort study. PloS one. 2020;15:e0234728.
Google Scholar
Dahlen HG, Barnett B, Kohlhoff J, Drum ME, Munoz AM, Thornton C. Obstetric and psychosocial risk factors for Australian-born and non-Australian born women and associated pregnancy and birth outcomes: a Population Based Cohort study. BMC Pregnancy Childbirth. 2015;15:292.
Google Scholar
Dayan J, Creveuil C, Marks MN, Conroy S, Herlicoviez M, Dreyfus M, et al. Prenatal depression, prenatal anxiety, and spontaneous preterm birth: a Prospective Cohort study among women with early and regular care. Psychosom Med. 2006;68:938–46.
Google Scholar
Diego MA, Field T, Hernandez-Reif M, Schanberg S, Kuhn C, Gonzalez-Quintero VH. Prenatal depression restricts fetal growth. Early Hum Dev. 2009;85:65–70.
Google Scholar
Dole N, Savitz DA, Hertz-Picciotto I, Siega-Riz AM, McMahon MJ, Buekens P. Maternal stress and preterm birth. Am J Epidemiol. 2003;157:14–24.
Google Scholar
Dowse E, Chan S, Ebert L, Wynne O, Thomas S, Jones D, et al. Impact of perinatal depression and anxiety on birth outcomes: a retrospective data analysis. Matern Child Health J. 2020;24:718–26.
Google Scholar
Evans J, Heron J, Patel RR, Wiles N. Depressive symptoms during pregnancy and low birth weight at term: Longitudinal study. Br J Psychiatry. 2007;191:84–5.
Google Scholar
Fransson E, Ortenstrand A, Hjelmstedt A. Antenatal depressive symptoms and preterm birth: a Prospective study of a Swedish national sample. Birth. 2011;38:10–6.
Google Scholar
Gavin AR, Holzman C, Siefert K, Tian Y. Maternal depressive symptoms, depression, and psychiatric medication use in relation to risk of preterm delivery. Womens Health Issues. 2009;19:325–34.
Google Scholar
Giurgescu C, Engeland CG, Templin TN. Symptoms of depression predict negative birth outcomes in African American women: a Pilot Study. J Midwifery Womens Health. 2015;60:570–7.
Google Scholar
Giurgescu C, Fahmy L, Slaughter-Acey J, Nowak A, Caldwell C, Misra DP. Can support from the father of the baby buffer the adverse effects of depressive symptoms on risk of Preterm birth in black families? AIMS Public Health. 2018;5:89–98.
Google Scholar
Goedhart G, Snijders AC, Hesselink AE, van Poppel MN, Bonsel GJ, Vrijkotte TG. Maternal depressive symptoms in relation to perinatal mortality and morbidity: results from a Large Multiethnic Cohort study. Psychosom Med. 2010;72:769–76.
Google Scholar
Hemavathy S, Deepa M, Uma R, Gowri R, Pradeepa R, Hannah W, et al. Prevalence of depression and anxiety among pregnant women with gestational diabetes mellitus in South Asia. Prim Care Diabetes. 2025;19:322–8.
Google Scholar
Ibanez G, Charles MA, Forhan A, Magnin G, Thiebaugeorges O, Kaminski M, et al. Depression and anxiety in women during pregnancy and neonatal outcome: data from the EDEN mother-child cohort. Early Hum Dev. 2012;88:643–9.
Google Scholar
Kabir K, Sheeder J, Stevens-Simon C. Depression, weight gain, and low birth weight adolescent delivery: do somatic symptoms strengthen or weaken the relationship? J Pediatr Adolesc Gynecol. 2008;21:335–42.
Google Scholar
Karim S, Cai B, Merchant AT, Wilcox S, Zhao X, Alston K, et al. Antenatal depressive symptoms and adverse birth outcomes in healthy start participants: the modifying role of utilization of mental health services. Midwifery. 2024;132:103985.
Google Scholar
Khanam R, Applegate J, Nisar I, Dutta A, Rahman S, Nizar A, et al. Burden and risk factors for antenatal depression and its effect on preterm birth in South Asia: a Population-Based Cohort study. PloS one. 2022;17:e0263091.
Google Scholar
Kim DR, Sockol LE, Sammel MD, Kelly C, Moseley M, Epperson CN. Elevated risk of adverse obstetric outcomes in pregnant women with depression. Arch Womens Ment Health. 2013;16:475–82.
Google Scholar
Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Ylikorkala O. Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol. 2000;95:487–90.
Google Scholar
Lalani S, Premji SS, Shaikh K, Sulaiman S, Yim IS, Forcheh N, et al. Individual and collective contribution of antenatal psychosocial distress conditions and preterm birth in Pakistani women. PLoS One. 2023;18:e0282582.
Google Scholar
Larsen A, Pintye J, Abuna F, Bhat A, Dettinger JC, Gomez L, et al. Risks of adverse perinatal outcomes in relation to maternal depressive symptoms: a Prospective Cohort study in Kenya. Paediatr Perinat Epidemiol. 2023;37:489–504.
Google Scholar
Li D, Liu L, Odouli R. Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: a Prospective Cohort study. Hum Reprod. 2009;24:146–53.
Google Scholar
Li J, Fan W, Wang X, Hou X, Chen Z, Lv M. Mental health in early pregnancy and spontaneous abortion risk: a Prospective Cohort Study. Alpha Psychiatry. 2024;25:648–55.
Google Scholar
Li X, Gao R, Dai X, Liu H, Zhang J, Liu X, et al. The association between symptoms of depression during pregnancy and low birth weight: a Prospective study. BMC Pregnancy Childbirth. 2020;20:147.
Google Scholar
Li Y, Chang JJ, Zuo R, Xian H, Scharff D. The moderating role of depression in the association between hypertension during pregnancy and birth outcomes. Hypertens Pregnancy. 2023;42:2226703.
Google Scholar
Liu Y, Murphy SK, Murtha AP, Fuemmeler BF, Schildkraut J, Huang Z, et al. Depression in pregnancy, infant birth weight and DNA methylation of imprint regulatory elements. Epigenetics. 2012;7:735–46.
Google Scholar
López DP, Serna LG, Arnáiz MCS, Ruiz MO, Viladegut JS, Sol J, et al. Outcomes of antenatal depression in women and the new-born: a Retrospective Cohort study. Family Practice. 2024;41:925–31.
Google Scholar
Luciano M, Di Vincenzo M, Brandi C, Tretola L, Toricco R, Perris F, et al. Does antenatal depression predict post-partum depression and obstetric complications? Results from a Longitudinal, Long-term, Real-world study. Front Psychiatry. 2022;13:1082762.
Google Scholar
Misra D, Strobino D, Trabert B. Effects of social and psychosocial factors on risk of preterm birth in black women. Paediatr Perinat Epidemiol. 2010;24:546–54.
Google Scholar
Mochache K, Mathai M, Gachuno O, Vander Stoep A, Kumar M. Depression during pregnancy and preterm delivery: a Prospective Cohort study among women attending antenatal clinic at Pumwani Maternity Hospital. Ann Gen Psychiatry. 2018;17:31.
Google Scholar
Morrison C, McCook JG, Bailey BA. First trimester depression scores predict development of gestational diabetes mellitus in pregnant rural Appalachian women. J Psychosom Obstet Gynaecol. 2016;37:21–5.
Google Scholar
Nasreen HE, Pasi HB, Rifin SM, Aris MAM, Rahman JA, Rus RM, et al. Impact of maternal antepartum depressive and anxiety symptoms on birth outcomes and mode of delivery: a Prospective Cohort study in east and west coasts of Malaysia. BMC Pregnancy Childbirth. 2019;19:201.
Google Scholar
Navaratne P, Foo XY, Kumar S. Impact of a high Edinburgh Postnatal Depression Scale score on obstetric and perinatal outcomes. Sci Rep. 2016;6:33544.
Google Scholar
Ncube CN, Enquobahrie DA, Gavin AR. Racial differences in the association between maternal antenatal depression and Preterm birth risk: a Prospective Cohort study. J Womens Health (Larchmt). 2017;26:1312–8.
Google Scholar
Netsi E, Coll CVN, Stein A, Silveira MF, Bertoldi AD, Bassani DG, et al. Female infants are more susceptible to the effects of maternal antenatal depression; findings from the Pelotas (Brazil) Birth Cohort study. J Affect Disord. 2020;267:315–24.
Google Scholar
Nidey NL, Momany AM, Strathearn L, Carter KD, Wehby GL, Bao W, et al. Association between perinatal depression and risk of attention deficit hyperactivity disorder among children: a retrospective cohort study. Ann Epidemio. 2021;63:1–6.
Google Scholar
Pan J, Zhu X, Xu L, Zhou L, Yin S, Qi X, et al. Effects of sleep quality, anxiety, and depression on miscarriage among pregnant women: a multi-center prospective observational study. Transl Psychiatry. 2025;15:131.
Google Scholar
Pathirana MM, Andraweera PH, Leemaqz S, Aldridge E, Arstall MA, Dekker GA, et al. Anxiety and depression in early gestation and the association with subsequent gestational diabetes mellitus in a disadvantaged population. Matern Child Health J. 2023;27:2185–93.
Google Scholar
Pawlby S, Hay DF, Sharp D, Waters CS, O’Keane V. Antenatal depression predicts depression in adolescent offspring: prospective Longitudinal Community-Based study. J Affect Disord. 2009;113:236–43.
Google Scholar
Pearson RM, Evans J, Kounali D, Lewis G, Heron J, Ramchandani PG, et al. Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry. 2013;70:1312–9.
Google Scholar
Rahman A, Bunn J, Lovel H, Creed F. Association between antenatal depression and low birthweight in a developing country. Acta Psychiatr Scand. 2007;115:481–6.
Google Scholar
Roy U, Swain D. A prospective cohort study to assess the prevalence and risk factors of antepartum depression and its effect on maternal and fetal outcome. Asian J Psychiatr. 2024;91:103873.
Google Scholar
Saeed A, Raana T, Saeed AM, Humayun A. Effect of antenatal depression on maternal dietary intake and neonatal outcome: a prospective cohort. Nutr J. 2016;15:64.
Google Scholar
Shuffrey LC, Lucchini M, Morales S, Sania A, Hockett C, Barrett E, et al. Gestational diabetes mellitus, prenatal maternal depression, and risk for postpartum depression: an Environmental influences on Child Health Outcomes (ECHO) study. BMC Pregnancy Childbirth. 2022;22:758.
Google Scholar
Stark EL, Shim J, Ross CM, Miller ES. The association between positive antenatal depression screening and breastfeeding initiation and continuation. Am J Perinatol. 2021;38:171–5.
Google Scholar
Steer RA, Scholl TO, Hediger ML, Fischer RL. Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol. 1992;45:1093–9.
Google Scholar
Straub H, Adams M, Kim JJ, Silver RK. Antenatal depressive symptoms increase the likelihood of preterm birth. Am J Obstet Gynecol. 2012;207:329.e1–4.
Google Scholar
Thombre MK, Talge NM, Holzman C. Association between pre-pregnancy depression/anxiety symptoms and hypertensive disorders of pregnancy. J Womens Health (Larchmt). 2015;24:228–36.
Google Scholar
Van Ngo T, Gammeltoft T, Nguyen HTT, Meyrowitsch DW, Rasch V. Antenatal depressive symptoms and adverse birth outcomes in Hanoi, Vietnam. PLoS One. 2018;13:e0206650.
Google Scholar
Venkataraman R, Yadav SK, Pukale RS. Factors affecting the depression and impact of depression on maternal outcomes: a Prospective Observational study from a rural tertiary care South Indian Hospital. Ital J Gynaecol Obstet. 2023;35:406–14.
Google Scholar
Venkatesh KK, Riley L, Castro VM, Perlis RH, Kaimal AJ. Association of antenatal depression symptoms and antidepressant treatment with Preterm birth. Obstet Gynecol. 2016;127:926–33.
Google Scholar
Versteegen M, Bozlak CT, Larkin H, Appleton AA. Maternal depression, adverse childhood experiences, and social support in relation to gestational diabetes risk: results from the Albany Infant and Mother Study (AIMS). BMC Pregnancy Childbirth. 2021;21:335.
Google Scholar
Wado YD, Afework MF, Hindin MJ. Effects of maternal pregnancy intention, depressive symptoms and social support on risk of low birth weight: a Prospective study from southwestern Ethiopia. PLoS One. 2014;9:e96304.
Google Scholar
Weobong B, ten Asbroek AH, Soremekun S, Manu AA, Owusu-Agyei S, Prince M, et al. Association of antenatal depression with adverse consequences for the mother and newborn in rural Ghana: findings from the DON Population-Based Cohort study. PLoS One. 2014;9:e116333.
Google Scholar
Yang J, Xu A, Zhang Y, Deng J, Lin X, Xie L, et al. Promoter methylation changes in the placenta involved in the relationship between prenatal depression and small for gestational age. BMC Pregnancy Childbirth. 2022;22:741.
Google Scholar
Zhang ZY, Yu JJ, Zeng WT, Zhou MC, Duan CC, Zhu LL. Association between antenatal depression and adverse perinatal outcomes: a Prospective Cohort study. J Affect Disord. 2023;323:490–5.
Google Scholar
Aliaga A, Cunillera O, Amador MDC, Aliaga M, Arquerons M, Almeda J. Association between affective disorders presenting before and during pregnancy and pre-term birth, considering socio-demographic factors, obstetric factors, health conditions, and use of medication. Aten Primaria. 2019;51:626–36.
Google Scholar
Andersen JT, Andersen NL, Horwitz H, Poulsen HE, Jimenez-Solem E. Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage. Obstet Gynecol. 2014;124:655–61.
Google Scholar
Andrade SE, McPhillips H, Loren D, Raebel MA, Lane K, Livingston J, et al. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf. 2009;18:246–52.
Google Scholar
Ankarfeldt MZ, Petersen J, Andersen JT, Li H, Motsko SP, Fast T, et al. Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: a Nationwide Cohort study in Denmark and Sweden. PLoS Med. 2021;18:e1003851.
Google Scholar
Ankarfeldt MZ, Petersen J, Andersen JT, Fernandes MFS, Li H, Motsko SP, et al. Duloxetine exposure during pregnancy and the risk of offspring being born small for gestational age or prematurely: a Nationwide Danish and Swedish Safety study. Drugs – Real World Outcomes. 2023;10:69–81.
Google Scholar
Berard A, Sheehy O, Zhao JP, Vinet E, Bernatsky S, Abrahamowicz M. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn. B J Clin Pharmacol. 2017;83:1126–33.
Google Scholar
Bliddal M, Wesselhoeft R, Strandberg-Larsen K, Ernst MT, Weissman MM, Gingrich JA, et al. Prenatal antidepressant exposure and emotional disorders until age 22: a Danish Register study. Child Adolesc Psychiatry Ment Health. 2023;17:73.
Google Scholar
Boukhris T, Sheehy O, Berard A. Antidepressant use in pregnancy and the risk of attention deficit with or without hyperactivity disorder in children. Paediatr Perinat Epidemiol. 2017;31:363–73.
Google Scholar
Boukhris T, Sheehy O, Mottron L, Berard A. Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr. 2016;170:117–24.
Google Scholar
Brown HK, Ray JG, Wilton AS, Lunsky Y, Gomes T, Vigod SN. Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children. JAMA. 2017;317:1544–52.
Google Scholar
Calderon-Margalit R, Qiu C, Ornoy A, Siscovick DS, Williams MA. Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy. Am J Obstet Gynecol. 2009;201:579.e1–8.
Google Scholar
Cantarutti A, Merlino L, Monzani E, Giaquinto C, Corrao G. Is the risk of preterm birth and low birth weight affected by the use of antidepressant agents during pregnancy? A population-based investigation. PLoS One. 2016;11:e0168115.
Google Scholar
Chan JKN, Lee KCK, Wong CSM, Chang WC. Prenatal antidepressant use and risk of congenital malformations: a Population-Based Cohort study. Psychiatry Res. 2024;339:116038.
Google Scholar
Chen LF, Lin CE, Chung CH, Lai CH, Chien WC. Association between the use of antidepressants and the risk of preterm birth among pregnant women with depression: a Retrospective Cohort study in Taiwan. J Investig Med. 2021;69:999–1007.
Google Scholar
Colvin L, Slack-Smith L, Stanley FJ, Bower C. Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy. Birth Defects Res A Clin Mol Teratol. 2011;91:142–52.
Google Scholar
Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, et al. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf. 2007;16:1086–94.
Google Scholar
Esen BO, Ehrenstein V, Sørensen HT, Laugesen K, Pedersen L. Prenatal antidepressant exposure and the risk of attention-deficit/hyperactivity disorder in childhood: a Cohort study with triangulation. Epidemiology. 2022;33:581–92.
Google Scholar
Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, et al. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: Population Based Cohort study and sibling design. BMJ. 2015;350:h1798.
Google Scholar
Grzeskowiak LE, Gilbert AL, Morrison JL. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors. J Clin Psychopharmacol. 2012;32:615–21.
Google Scholar
Grzeskowiak LE, McBain R, Dekker GA, Clifton VL. Antidepressant use in late gestation and risk of postpartum haemorrhage: a Retrospective Cohort study. BJOG. 2016;123:1929–36.
Google Scholar
Hanley GE, Smolina K, Mintzes B, Oberlander TF, Morgan SG. Postpartum hemorrhage and use of serotonin reuptake inhibitor antidepressants in pregnancy. Obstet Gynecol. 2016;27:553–61.
Google Scholar
Heller HM, Ravelli ACJ, Bruning AHL, de Groot CJM, Scheele F, van Pampus MG, et al. Increased postpartum haemorrhage, the possible relation with serotonergic and other psychopharmacological drugs: a Matched Cohort study. BMC Pregnancy Childbirth. 2017;17:166.
Google Scholar
Heuvelman H, Davies NM, Ben-Shlomo Y, Emond A, Evans J, Gunnell D, et al. Antidepressants in pregnancy: applying causal epidemiological methods to understand service-use outcomes in women and long-term neurodevelopmental outcomes in exposed children. Health Technol Assess. 2023;27:1–83.
Google Scholar
Hutchison SM, Brain U, Grunau RE, Kuzeljevic B, Irvine M, Mâsse LC, et al. Associations between maternal depressive symptoms and selective serotonin reuptake inhibitor antidepressant treatment on internalising and anxiety behaviours in children: 12-year Longitudinal study. BJPsych Open. 2023;9:e26.
Google Scholar
Huybrechts KF, Bateman BT, Palmsten K, Desai RJ, Patorno E, Gopalakrishnan C, et al. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA. 2015;313:2142–51.
Google Scholar
Huybrechts KF, Bateman BT, Pawar A, Bessette LG, Mogun H, Levin R, et al. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: Cohort study. BMJ. 2020;368:m237.
Google Scholar
Hwang YM, Roper RT, Piekos SN, Enquobahrie DA, Hebert MF, Paquette AG, et al. Timing of selective serotonin reuptake inhibitor use and risk for preterm birth and related adverse events: with a consideration of the COVID-19 pandemic period. J Matern Fetal Neonatal Med. 2024;37:2313364.
Google Scholar
Jimenez-Solem E, Andersen JT, Petersen M, Broedbaek K, Lander AR, Afzal S, et al. SSRI use during pregnancy and risk of stillbirth and neonatal mortality. Am J Psychiatry. 2013;170:299–304.
Google Scholar
Jordan S, Morris JK, Davies GI, Tucker D, Thayer DS, Luteijn JM, et al. Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants in pregnancy and congenital anomalies: analysis of linked databases in wales, Norway and Funen, Denmark. PLoS One. 2016;11:e0165122.
Google Scholar
Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: Population Based Cohort study from the five Nordic countries. BMJ. 2012;344:d8012.
Google Scholar
Kim DR, Pinheiro E, Luther JF, Eng HF, Dills JL, Wisniewski SR, et al. Is third trimester serotonin reuptake inhibitor use associated with postpartum hemorrhage? J Psychiatr Res. 2016;73:79–85.
Google Scholar
Kivisto J, Lehto SM, Halonen K, Georgiadis L, Heinonen S. Maternal use of selective serotonin reuptake inhibitors and lengthening of the umbilical cord: indirect evidence of increased foetal activity-a Retrospective Cohort study. PLoS One. 2016;11:e0154628.
Google Scholar
Kolding L, Ehrenstein V, Pedersen L, Sandager P, Petersen OB, Uldbjerg N, et al. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study. BJOG. 2021;128:1949–57.
Google Scholar
Laine MK, Masalin S, Rono K, Kautiainen H, Gissler M, Pennanen P, et al. Risk of preterm birth in primiparous women with exposure to antidepressant medication before pregnancy and/or during pregnancy – impact of body mass index. Ann Med. 2019;51:51–7.
Google Scholar
Laugesen K, Olsen MS, Telen Andersen AB, Froslev T, Sorensen HT. In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: a nationwide Danish Cohort study. BMJ Open. 2013;3:e003507.
Google Scholar
Lee KCK, Fung VSC, Chan JKN, Wong CSM, Cheung KW, Seto MTY, et al. Antidepressant use during pregnancy and risk of obstetrics and neonatal outcomes: a Propensity Score-Weighted Population-Based Cohort study in 2003–2018. Eur Neuropsychopharmacol. 2025;96:36–45.
Google Scholar
Lee MJ, Chen YL, Wu SI, Huang CW, Dewey ME, Chen VC. Association between maternal antidepressant use during pregnancy and the risk of autism spectrum disorder and attention deficit hyperactivity disorder in offspring. Eur Child Adolesc Psychiatry. 2024;33:4273–83.
Google Scholar
Leibovitch L, Rymer-Haskel N, Schushan-Eisen I, Kuint J, Strauss T, Maayan-Metzger A. Short-term neonatal outcome among term infants after in utero exposure to serotonin reuptake inhibitors. Neonatology. 2013;104:65–70.
Google Scholar
Lindqvist PG, Nasiell J, Gustafsson LL, Nordstrom L. Selective serotonin reuptake inhibitor use during pregnancy increases the risk of postpartum hemorrhage and anemia: a Hospital-Based Cohort study. J Thromb Haemost. 2014;12:1986–92.
Google Scholar
Lund N, Pedersen LH, Henriksen TB. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med. 2009;163:949–54.
Google Scholar
Lupattelli A, Barone-Adesi F, Nordeng H. Association between antidepressant use in pregnancy and gestational diabetes mellitus: results from the Norwegian Mother, Father and Child Cohort study. Pharmacoepidemiol Drug Saf. 2022;31:247–56.
Google Scholar
Lupattelli A, Wood M, Lapane K, Spigset O, Nordeng H. Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: a study from The Norwegian Mother and Child Cohort study. Pharmacoepidemiol Drug Saf. 2017;26:1266–76.
Google Scholar
Malm H, Artama M, Gissler M, Ritvanen A. Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstet Gynecol. 2011;118:111–20.
Google Scholar
Malm H, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomaki S, McKeague IW, et al. Gestational exposure to selective serotonin reuptake inhibitors and offspring psychiatric disorders: a National Register-Based study. J Am Acad Child Adolesc Psychiatry. 2016;55:359–66.
Google Scholar
Malm H, Sourander A, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague IW, et al. Pregnancy complications following prenatal exposure to SSRIs or maternal psychiatric disorders: results from Population-Based National Register data. Am J Psychiatry. 2015;172:1224–32.
Google Scholar
Man KKC, Chan EW, Ip P, Coghill D, Simonoff E, Chan PKL, et al. Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: Population Based Cohort study. BMJ. 2017;357:j2350.
Google Scholar
Mao Y, Pedersen LH, Christensen J, Vestergaard M, Zhou W, Olsen J, et al. Prenatal exposure to antidepressants and risk of epilepsy in childhood. Pharmacoepidemiol Drug Saf. 2016;25:1320–30.
Google Scholar
Nishigori H, Obara T, Nishigori T, Mizuno S, Metoki H, Hoshiai T, et al. Selective serotonin reuptake inhibitors and risk of major congenital anomalies for pregnancies in Japan: a Nationwide Birth Cohort study of the Japan Environment and Children’s study. Congenit Anom (Kyoto). 2017;57:72–8.
Google Scholar
Norby U, Forsberg L, Wide K, Sjors G, Winbladh B, Kallen K. Neonatal morbidity after maternal use of antidepressant drugs during pregnancy. Pediatrics. 2016;138:e20160181.
Google Scholar
Nordeng H, van Gelder MM, Spigset O, Koren G, Einarson A, Eberhard-Gran M. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort study. J Clin psychopharmacol. 2012;32:186–94.
Google Scholar
Oberlander TF, Warburton W, Misri S, Riggs W, Aghajanian J, Hertzman C. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol. 2008;83:68–76.
Google Scholar
Öndemark M, Nordström L, Lindqvist PG. Dose-dependent increase in risk of bleeding and bleeding complications in relation to SSRI use at delivery. Eur J Obstet Gynecol Reprod Biol. 2024;296:265–9.
Google Scholar
Ostenfeld A, Petersen TS, Pedersen LH, Westergaard HB, Løkkegaard ECL, Andersen JT. Mirtazapine exposure in pregnancy and fetal safety: a Nationwide Cohort study. Acta Psychiatr Scand. 2022;145:557–67.
Google Scholar
Palmsten K, Chambers CD, Wells A, Bandoli G. Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage. Paediatr Perinat Epidemiol. 2020;34:597–606.
Google Scholar
Palmsten K, Hernández-Díaz S, Huybrechts KF, Williams PL, Michels KB, Achtyes ED, et al. Use of antidepressants near delivery and risk of postpartum hemorrhage: Cohort study of low income women in the United States. BMJ. 2013;347:f4877.
Google Scholar
Palmsten K, Huybrechts KF, Michels KB, Williams PL, Mogun H, Setoguchi S, et al. Antidepressant use and risk for preeclampsia. Epidemiology. 2013;24:682–91.
Google Scholar
Palmsten K, Setoguchi S, Margulis AV, Patrick AR, Hernandez-Diaz S. Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants? Am J Epidemiol. 2012;175:988–97.
Google Scholar
Rai D, Lee BK, Dalman C, Newschaffer C, Lewis G, Magnusson C. Antidepressants during pregnancy and autism in offspring: population Based Cohort study. BMJ. 2017;358:j2811.
Google Scholar
Skalkidou A, Sundström-Poromaa I, Wikman A, Hesselman S, Wikström AK, Elenis E. SSRI use during pregnancy and risk for postpartum haemorrhage: a National Register-Based Cohort study in Sweden. BJOG. 2020;127:1366–73.
Google Scholar
Skurtveit S, Selmer R, Tverdal A, Furu K, Nystad W, Handal M. Drug exposure: inclusion of dispensed drugs before pregnancy may lead to underestimation of risk associations. J Clin Epidemiol. 2013;66:964–72.
Google Scholar
Sørensen MJ, Grønborg TK, Christensen J, Parner ET, Vestergaard M, Schendel D, et al. Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol. 2013;5:449–59.
Google Scholar
Stephansson O, Kieler H, Haglund B, Artama M, Engeland A, Furu K, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. JAMA. 2013;309:48–54.
Google Scholar
Suarez EA, Bateman BT, Hernández-Díaz S, Straub L, Wisner KL, Gray KJ, et al. Association of antidepressant use during pregnancy with risk of neurodevelopmental disorders in children. JAMA Intern Med. 2022;182:1149–60.
Google Scholar
Sujan AC, Rickert ME, Oberg AS, Quinn PD, Hernandez-Diaz S, Almqvist C, et al. Associations of maternal antidepressant use during the first trimester of pregnancy with Preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring. JAMA. 2017;317:1553–62.
Google Scholar
Toh S, Mitchell AA, Louik C, Werler MM, Chambers CD, Hernandez-Diaz S. Selective serotonin reuptake inhibitor use and risk of gestational hypertension. Am J Psychiatry. 2009;166:320–8.
Google Scholar
Tran YH, Huynh HK, Faas MM, de Vos S, Groen H. Antidepressant use during pregnancy and development of preeclampsia: a focus on classes of action and specific transporters/receptors targeted by antidepressants. J Psychiatr Res. 2022;146:92–101.
Google Scholar
Ulbrich KA, Zumpf K, Ciolino JD, Shah M, Miller ES, Wisner KL. Acute delivery room resuscitation of neonates exposed to selective serotonin reuptake inhibitors. J Pediatr. 2021;232:103–8.
Google Scholar
Vasilakis-Scaramozza C, Aschengrau A, Cabral H, Jick SS. Antidepressant use during early pregnancy and the risk of congenital anomalies. Pharmacotherapy. 2013;33:693–700.
Google Scholar
Vignato JA, Gumusoglu SB, Davis HA, Scroggins SM, Hamilton WS, Brandt DS, et al. Selective serotonin reuptake inhibitor use in pregnancy and protective mechanisms in preeclampsia. Reprod Sci. 2023;30:701–12.
Google Scholar
Wen SW, Yang Q, Garner P, Fraser W, Olatunbosun O, Nimrod C, et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol. 2006;194:961–6.
Google Scholar
Wichman CL, Moore KM, Lang TR, St Sauver JL, Heise RH Jr, Watson WJ. Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy. Mayo Clin Proc. 2009;84:23–7.
Google Scholar
Wiggs KK, Sujan AC, Rickert ME, Quinn PD, Larsson H, Lichtenstein P, et al. Maternal serotonergic antidepressant use in pregnancy and risk of seizures in children. Neurology. 2022;98:e2329–36.
Google Scholar
Wu P, Velez Edwards DR, Gorrindo P, Sundermann AC, Torstenson ES, Jones SH, et al. Association between first trimester antidepressant use and risk of spontaneous abortion. Pharmacotherapy. 2019;39:889–98.
Google Scholar
Yamamoto-Sasaki M, Yoshida S, Takeuchi M, Tanaka-Mizuno S, Ogawa Y, Furukawa TA, et al. Association between antidepressant use during pregnancy and autism spectrum disorder in children: a Retrospective Cohort study based on Japanese claims data. Matern Health Neonatol Perinatol. 2019;5:1.
Google Scholar
Zakiyah N, Ter Heijne LF, Bos JH, Hak E, Postma MJ, Schuiling-Veninga CCM. Antidepressant use during pregnancy and the risk of developing gestational hypertension: a Retrospective Cohort study. BMC Pregnancy Childbirth. 2018;18:187.
Google Scholar
Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics. 2004;113:368–75.
Google Scholar
Adhikari K, Patten SB, Lee S, Metcalfe A. Risk of adverse perinatal outcomes among women with pharmacologically treated and untreated depression during pregnancy: a Retrospective Cohort study. Paediatr Perinat Epidemiol. 2019;33:323–31.
Google Scholar
Avalos LA, Chen H, Li DK. Antidepressant medication use, depression, and the risk of preeclampsia. CNS Spectr. 2015;20:39–47.
Google Scholar
Ban L, Gibson JE, West J, Fiaschi L, Sokal R, Smeeth L, et al. Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a Population-Based Cohort study. BJOG. 2014;121:1471–81.
Google Scholar
Beck-Pancer D, Aghaee S, Swint A, Acker J, Deardorff J, Kubo A. Maternal depression and antidepressant use during pregnancy and associations with depressive symptoms and suicidality in adolescent children. Clin Epidemiol. 2023;15:613–28.
Google Scholar
Cheng CC, Siong K, Lee HC, Kau Y. Effect of depressive disorders and other psychiatric disorders on pregnancy and perinatal outcomes in a Hong Kong obstetrics unit. Hong Kong J Gynaecol Obstet Midwifery. 2020;20:22–6.
Google Scholar
El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A, et al. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry. 2012;69:706–14.
Google Scholar
Engelstad HJ, Roghair RD, Calarge CA, Colaizy TT, Stuart S, Haskell SE. Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy. Neonatology. 2014;105:149–54.
Google Scholar
Hagberg KW, Robijn AL, Jick S. Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring. Clin Epidemiol. 2018;10:1599–612.
Google Scholar
Herrero T, Driebe A, Fratto V, Hamlin A, Lacoursiere DY, Ramos GA. Positive antenatal Edinburgh Depression Scale: examining behavioral and pharmacological therapy on maternal and neonatal outcomes. J Matern Fetal Neonatal Med. 2020;33:212–6.
Google Scholar
Huang HC, Sung FC, Chen PC, Chang CY, Muo CH, Shiue HS, et al. Obstetric outcomes in pregnant women with and without depression: population-based comparison. Sci Rep. 2017;7:13937.
Google Scholar
Jensen HM, Gron R, Lidegaard O, Pedersen LH, Andersen PK, Kessing LV. Maternal depression, antidepressant use in pregnancy and Apgar scores in infants. Br J Psychiatry. 2013;202:347–51.
Google Scholar
Jensen HM, Gron R, Lidegaard O, Pedersen LH, Andersen PK, Kessing LV. The effects of maternal depression and use of antidepressants during pregnancy on risk of a child small for gestational age. Psychopharmacology (Berl). 2013;228:199–205.
Google Scholar
Jordan S, Davies GI, Thayer DS, Tucker D, Humphreys I. Antidepressant prescriptions, discontinuation, depression and perinatal outcomes, including breastfeeding: a population cohort analysis. PLoS One. 2019;14:e0225133.
Google Scholar
Kjaersgaard MI, Parner ET, Vestergaard M, Sorensen MJ, Olsen J, Christensen J, et al. Prenatal antidepressant exposure and risk of spontaneous abortion – a Population-Based study. PLoS One. 2013;8:e72095.
Google Scholar
Michihata N, Shigemi D, Yamana H, Matsui H, Jo T, Yasunaga H. Safety of Japanese herbal Kampo medicines for the treatment of depression during pregnancy. Int J Gynaecol Obstet. 2022;159:865–9.
Google Scholar
Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006;63:898–906.
Google Scholar
Sahingoz M, Yuksel G, Karsidag C, Uguz F, Sonmez EO, Annagur BB, et al. Birth weight and preterm birth in babies of pregnant women with major depression in relation to treatment with antidepressants. J Clin Psychopharmacol. 2014;34:226–9.
Google Scholar
Seebeck J, Sznajder KK, Kjerulff KH. The association between prenatal psychosocial factors and autism spectrum disorder in offspring at 3 years: a Prospective Cohort study. Soc Psychiatry Psychiatr Epidemiol. 2024;59:1639–49.
Google Scholar
Suri R, Altshuler L, Hellemann G, Burt VK, Aquino A, Mintz J. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry. 2007;164:1206–13.
Google Scholar
Watson SJ, Spigset O. Depression and antidepressant treatment in the development of hypertensive disorders of pregnancy: results from a Prospective Cohort study. Aust N Z J Psychiatry. 2023;57:520–7.
Google Scholar
Wisner KL, Sit DK, Hanusa BH, Moses-Kolko EL, Bogen DL, Hunker DF, et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry. 2009;166:557–66.
Google Scholar
Kautzky A, Slamanig R, Unger A, Höflich A. Neonatal outcome and adaption after in utero exposure to antidepressants: a systematic review and meta-analysis. Acta Psychiatr Scand. 2022;145:6–28.
Google Scholar
Cornet MC, Wu YW, Forquer H, Avalos LA, Sriram A, Scheffler AW, et al. Maternal treatment with selective serotonin reuptake inhibitors during pregnancy and delayed neonatal adaptation: a Population-Based Cohort study. Arch Dis Child Fetal Neonatal Ed. 2024;109:294–300.
Google Scholar
MacQueen GM, Frey BN, Ismail Z, Jaworska N, Steiner M, Lieshout RJ, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 6. Special Populations: Youth, Women, and the Elderly. Can J Psychiatry. 2016;61:588–603.
Google Scholar
Eke AC, Saccone G, Berghella V. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis. BJOG. 2016;123:1900–7.
Google Scholar
Roubinov D, Don B, Blades R, Epel E. Is it me or my child? The association between maternal depression and children’s behavior problems in mothers and their children with or without autism. Fam Process. 2023;62:737–53.
Google Scholar
Glover V. Maternal depression, anxiety and stress during pregnancy and child outcome; what needs to be done. Best Pract Res Clin Obstet Gynaecol. 2014;28:25–35.
Google Scholar
Hu R, Li Y, Zhang Z, Yan W. Antenatal depressive symptoms and the risk of preeclampsia or operative deliveries: a meta-analysis. PLoS One. 2015;10:e0119018.
Google Scholar
Liu M. Potenitial risk factors of cardiovascular diseases and mental disorders. Heart Mind. 2023;7:55–6.
Google Scholar
Clark H, Khosla R. The partnership for maternal, newborn, and child health: 2026–30 strategy. Lancet. 2025;406:596–7.
Google Scholar
Carlini SV, Deligiannidis KM. Poor neonatal adaptation syndrome: toward a clinical consensus to guide research and counseling. Acta Psychiatr Scand. 2022;145:3–5.
Google Scholar
link
